The Impact of Proton Pump Inhibitor Therapy on Outcomes in COVID-19 Patients: A Retrospective, Multicenter Study
Abdulhadi M. Alqahtani, Saja H. Almazrou, Khaled Alqahtani, Pendo Ntinika, Mohammed Alshahrani, Basmah F. Alqahtani, Amin K. Khattab, Sheikhah A. Alyahya, Fahad Dakilallah Aljohani, Hossein M. Elbadawy
Journal of Pharmaceutical Research International · pp. 3176–3184 · Published 27 Dec 2021
10.9734/jpri/2021/v33i60B34994Abstract
Background: Proton pump inhibitor (PPI)–coated prodrugs remain inactive until they enter the alkaline atmosphere of the duodenum, where they are absorbed and transmitted to parietal cells. This study aimed to evaluate the impact of PPI medication on patients with coronavirus disease 2019 (COVID-19) and their outcomes. Methods: This was a retrospective, multicenter study conducted at two regional hospitals in Saudi Arabia. All confirmed COVID-19 patients between March 1 and August 15, 2020, were included in the study. The Mann–Whitney U and chi-squared tests were performed to appropriately determine the difference between treatment groups. Results: Out of 346 patients, 136 (39.3 %) were users of PPIs with standard care, and 210 (60.7%) standard care and the average age was 43.5 years. The mean hospital length of stay in users of PPIs with standard care was 4.25 days. In contrast, the death cases of PPIs with standard care group were 3 cases out of 9 cases. Conclusion: The impact of PPIs on COVID-19 patients is so far still a debate, and the discovery of novel therapies for COVID-19 is paramount. However, it is important for scientists and treating physicians to thoroughly identify the comorbidities of patients and other treatments before PPI administration.
Cited by 0
No indexed citations yet.
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.